Canopy Growth Corporation CGC Business Segments
| FY'26 | FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|---|
| Revenue by Business | |||||
| Cannabis | $213.94M+14.6% | $186.73M-2.6% | $191.68M— | —— | |
| Storz And Bickel | $70.66M-14.1% | $82.27M+3.5% | $79.46M+22.5% | $64.85M-24.1% | |
| Gross Profit by Business | |||||
| Cannabis | $46.09M-5.9% | $49M+23.2% | $39.78M— | —— | |
| Storz And Bickel | $23.58M-22.7% | $30.52M-6.6% | $32.67M+25.1% | $26.11M-30.0% | |
| Revenue (Gross) by Product | |||||
| Canadian Adult Use Cannabis | $94.47M+19.8% | $78.83M-15.1% | $92.8M-30.5% | $133.59M— | |
| Canadian Medical Cannabis | $90.82M+17.9% | $77.03M+16.1% | $66.36M+7.3% | $61.86M— | |
| International Markets Cannabis | $28.65M-7.2% | $30.87M-5.1% | $32.52M-16.5% | $38.95M-50.9% | |
| Storz Bickel | $70.66M-14.1% | $82.27M+3.5% | $79.46M+22.5% | $64.85M-24.1% | |
| Revenue by Product | |||||
| Canadian Adult Use Cannabis | $51.86M+42.3% | $36.44M-9.2% | $40.12M-6.9% | $43.07M— | |
| Canadian Medical Cannabis | $10.37M+21.5% | $8.53M+27.9% | $6.67M+35.5% | $4.93M— | |
| Revenue by Geography | |||||
| CA | $186.09M+19.4% | $155.91M-4.2% | $162.71M-24.4% | $215.09M-19.8% | |
| DE | $62.07M+3.6% | $59.9M+14.8% | $52.19M+7.2% | $48.7M-46.4% | |
| US | $28.27M-21.5% | $35.99M-12.2% | $40.99M+12.5% | $36.45M-44.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Canopy Growth Corporation break its business down?
- Canopy Growth Corporation (CGC) reports revenue by business across 2 parts — Cannabis and Storz And Bickel. Each is extracted from the segment footnotes and tracked over time.
- Where does Canopy Growth Corporation's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Canopy Growth Corporation's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
